Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase II, open, non-randomized study designed to evaluate the reactogenicity and immunogenicity of one or two booster administrations of an influenza pandemic candidate vaccine (GSK1562902A) in adults aged between 19 and 61 years, previously vaccinated with 2 doses of a pandemic candidate vaccine H5N1 A/Vietnam/1194/2004 containing 3.8, 7.5, 15 or 30 µg HA, adjuvanted or not with AS03 https://kusajili.com:443/Trial/0oRf_W8t8k-e6Fui_jHxVw%24a-phase-ii-open-non-randomized-study-designed-to-evaluate-the-reactogenicity-and-immunogenicity-of-one-or-two-booster-administr
I have read and accept the terms of use of the site and the Privacy Policy
Send your message